Back to search

Article

SARS-CoV-2 Delta Breakthrough Infections in Vaccinated Patients with Immune-Mediated Inflammatory Diseases Using Immunosuppressants – Data from Two Controlled Prospective Cohort Studies

2022-03-16

Abstract excerpt

Background: The primary objective of this study was to compare the incidence and severity of SARS-CoV-2 breakthrough infections between vaccinated patients with immune-mediated inflammatory diseases (IMIDs) using immunosuppressants, and controls (IMID patients without immunosuppressants and healthy controls). The secondary objective was to explore determinants of breakthrough infections, including humoral immune r...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0c54aefb-b9ad-5410-9a30-ad995eeab85a
DOI
10.2139/ssrn.4035408
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
SARS-CoV-2 Delta Breakthrough Infections in Vaccinated Patients with Immune-Mediated Inflammatory Diseases Using Immunosuppressants – Data from Two Controlled Prospective Cohort StudiesDOI 10.2139/ssrn.4035408
Factors Associated with COVID-19 Breakthrough Infection in the Pre-Omicron Era Among Vaccinated Patients with Rheumatic Diseases: A Cohort StudySemantic proximity
Evaluation of COVID-19 vaccine breakthrough infections among immunocompromised patients fully vaccinated with BNT162b2Semantic proximity
Clinical characteristics and outcomes of COVID-19 breakthrough infections among vaccinated patients with systemic autoimmune rheumatic diseasesSemantic proximity
SARS-CoV-2 vaccine Alpha and Delta variant breakthrough infections are rare and mild, but happen relative early after vaccinationSemantic proximity
Incidence and risk factors of omicron variant SARS-CoV-2 breakthrough infection among vaccinated and boosted individualsSemantic proximity
SARS-CoV-2 Vaccine-Induced Antibodies Protect Against Omicron Breakthrough InfectionSemantic proximity
Breakthrough Infections with Multiple Lineages of SARS-CoV-2 Variants Reveals Continued Risk of Severe Disease in Immunosuppressed Patients.Semantic proximity
Investigating SARS-CoV-2 breakthrough infections per variant and vaccine typeSemantic proximity
Anti-SARS-CoV-2 immunogenicity decay and incident cases six months after Sinovac-CoronaVac inactivated vaccine in autoimmune rheumatic diseases patients: phase 4 prospective trialSemantic proximity
Comprehensive genomic, immunological and clinical analysis of COVID-19 vaccine breakthrough infections: a prospective, comparative cohort studySemantic proximity
Immunomodulators and risk for breakthrough infection after third COVID-19 mRNA vaccine among patients with rheumatoid arthritis: A cohort studySemantic proximity
Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infectionsSemantic proximity
Select a neighboring publication to make it the new centre.